- Home
- KNOP vs SCPH Comparison
KNOP vs SCPH Comparison
Compare KNOP & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNOP
- SCPH
- Stock Information
- Founded
- KNOP 2013
- SCPH 2013
- Country
- KNOP United Kingdom
- SCPH United States
- Employees
- KNOP N/A
- SCPH N/A
- Industry
- KNOP Marine Transportation
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- KNOP Consumer Discretionary
- SCPH Health Care
- Exchange
- KNOP Nasdaq
- SCPH Nasdaq
- Market Cap
- KNOP 187.6M
- SCPH 179.6M
- IPO Year
- KNOP 2013
- SCPH 2017
- Fundamental
- Price
- KNOP $5.91
- SCPH $3.42
- Analyst Decision
- KNOP
- SCPH Strong Buy
- Analyst Count
- KNOP 0
- SCPH 2
- Target Price
- KNOP N/A
- SCPH $15.00
- AVG Volume (30 Days)
- KNOP 109.7K
- SCPH 432.9K
- Earning Date
- KNOP 02-24-2025
- SCPH 03-12-2025
- Dividend Yield
- KNOP 1.74%
- SCPH N/A
- EPS Growth
- KNOP N/A
- SCPH N/A
- EPS
- KNOP N/A
- SCPH N/A
- Revenue
- KNOP $299,790,000.00
- SCPH $30,278,000.00
- Revenue This Year
- KNOP $7.66
- SCPH $172.64
- Revenue Next Year
- KNOP $1.75
- SCPH $131.43
- P/E Ratio
- KNOP N/A
- SCPH N/A
- Revenue Growth
- KNOP 4.75
- SCPH 303.87
- 52 Week Low
- KNOP $4.94
- SCPH $3.08
- 52 Week High
- KNOP $9.11
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- KNOP 51.68
- SCPH 46.85
- Support Level
- KNOP $5.88
- SCPH $3.27
- Resistance Level
- KNOP $6.13
- SCPH $3.59
- Average True Range (ATR)
- KNOP 0.23
- SCPH 0.19
- MACD
- KNOP 0.04
- SCPH 0.01
- Stochastic Oscillator
- KNOP 56.25
- SCPH 31.25
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.